Similar Articles
741 Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
742 Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
743 Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review
744 Liver transplantation for hepatocellular carcinoma: Where do we stand?
745 Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
746 Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
747 Mechanisms of hepatocellular carcinoma progression
748 Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
749 Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
750 ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA